Evaluation of a paraffin‐based moisturizer compared to a ceramide‐based moisturizer in children with atopic dermatitis: A double‐blind, randomized controlled trial
Pediatric Dermatology · 2023
DOI: 10.1111/pde.15355 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Dermatology, 2023. Verfasst von Sachin Gupta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Alkem Laboratories Ltd., Emcure Pharmaceuticals.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Moisturizers are first‐line therapy for treatment of atopic dermatitis (AD). Although there are multiple types of moisturizers available, head‐to‐head trials between different moisturizers are limited.
Objective
To evaluate if a paraffin‐based moisturizer is as effective as ceramide‐based moisturizer in children with AD. Materials and Methods In this double‐blind, randomized comparative trial of pediatric patients with mild to moderate AD, subjects applied either a paraffin‐based or ceramide‐based moisturizer twice daily. Clinical disease activity using SCOring Atopic Dermatitis (SCORAD), quality of life using Children/Infants Dermatology Life Quality Index (CDLQI/IDLQI), and transepidermal water loss (TEWL) were measured at baseline and at follow‐up at 1, 3, and 6 months.
Results
Fifty‐three patients were recruited (27 ceramide group and 26 paraffin group) with a mean age of 8.2 years and mean disease duration of 60 months. The mean change in SCORAD at 3 months in the ceramide‐based and paraffin‐based moisturizer groups was 22.1 and 21.4, respectively ( p = .37). The change in CDLQI/IDLQI, TEWL over forearm and back, amount and days of topical corticosteroid required, median time to remission and disease‐free days at 3 months were similar in both groups. As the 95% confidence interval (CI) of mean change in SCORAD at 3 months in both groups (0.78, 95% CI: −7.21 to 7.52) was not within the predefined margin of equivalence (−4 to +4), the conclusion of equivalence could not be proven.
Conclusion
Both the paraffin‐based and ceramide‐based moisturizers were comparable in improving the disease activity in children with mild to moderate AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
- School of Medical Science and Research, Sharda University, Greater Noida, Uttar Pradesh, India.
- Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.
ORCID-Profile: Sachin Gupta, Neetu Bhari
Förderung
- Alkem Laboratories Ltd.
- Emcure Pharmaceuticals
Zitieren
APA
Gupta, S., Ramam, M., Sharma, V. K., Sethuraman, G., Pandey, R. M., & Bhari, N. (2023). Evaluation of a paraffin‐based moisturizer compared to a ceramide‐based moisturizer in children with atopic dermatitis: A double‐blind, randomized controlled trial. Pediatric Dermatology. https://doi.org/10.1111/pde.15355
Vancouver
Gupta S, Ramam M, Sharma VK, Sethuraman G, Pandey RM, Bhari N. Evaluation of a paraffin‐based moisturizer compared to a ceramide‐based moisturizer in children with atopic dermatitis: A double‐blind, randomized controlled trial. Pediatric Dermatology. 2023. doi:10.1111/pde.15355
BibTeX
@article{Gupta2023,
author = {Gupta, Sachin and Ramam, M and Sharma, V K and Sethuraman, G and Pandey, R M and Bhari, Neetu},
title = {Evaluation of a paraffin‐based moisturizer compared to a ceramide‐based moisturizer in children with atopic dermatitis: A double‐blind, randomized controlled trial},
journal = {Pediatric Dermatology},
year = {2023},
doi = {10.1111/pde.15355}
}
EUVIMED